News • Blogs • Videos •
Forward to Friend
NSP Logo
Nicotine Science and Policy
Daily Digest - Friday, 17 March 2017

Department of Defense anti-smokeless campaign is ’50’ shades darker

February is a popular month for tobacco prohibitionists to attack smokeless tobacco, or “ST.” A year ago, I refuted seven false claims on the topic from county health departments. This year, the U.S. Department of Defense has escalated the attack. Thanks to David Sweanor of the University of Ottawa Centre for Health Law, Policy & Ethics, we became aware of an outrageous DOD website called UCanQuit.


Smoking cessation programs benefit patients prior to joint replacements

Smokers who needed a hip or knee replacement experienced better surgical outcomes and fewer adverse events including hospital readmissions, surgical site infections and blood clots if they were enrolled in a smoking cessation program prior to surgery, according to preliminary new research that needs to be confirmed by larger studies.


Poor, minority neighborhoods have more tobacco-selling shops per capita

Neighborhoods with a high proportion of black residents or high poverty tend to have the greatest density of stores selling cigarettes and tobacco products, U.S. researchers say. “The neighborhood you live in shouldn’t determine how much cancer-causing product is present in your day-to-day life,” said lead study author Joseph Lee [...] “The tobacco industry spends a large portion of its advertising budget at retailers, [...]


What the FDA Gets Wrong About E-Cigarettes

President Donald Trump’s nomination of Scott Gottlieb to be the next commissioner of the Food and Drug Administration is a hopeful sign that the FDA’s illogical tobacco product regulations may soon end. The rules as they stand lump all nicotine-containing products in the same basket, regardless of what risks they pose, so that electronic cigarettes [...] cannot remain on the market unless [...]


Smoking Cessation Drug May Boost Cognition in Schizophrenia

The smoking cessation drug varenicline (Chantix, Pfizer) appears to enhance cognition in nonsmoking individuals with and those without schizophrenia, new research indicates. "Given the high prevalence of smoking in patients with schizophrenia and some of the associated cognitive deficits found in these patients, having a smoking cessation aid that also targets these cognitive deficits would be ideal," lead author Karolina Kozak, [...]


'There is NO difference between vaping and smoking' [...]

Vapers may have kicked the habit, but they risk invalidating their insurance policies. When you apply for many insurance policies, like health insurance or life insurance, you’ll be asked whether you’re a smoker or not. Understandably if you’ve ditched the fags and moved over to e-cigs, you might feel entitled to say that you aren’t an active smoker.


Visit "" for more news
Copyright © 2017 Nicotine Science and Policy, All rights reserved.

unsubscribe from this list    update subscription preferences 

Email Marketing Powered by Mailchimp